Topics › Health Sciences › Medicine › Infectious Diseases
Viral Infections and Outbreaks Research Sign in to save
Papers per year
Papers 66
Open in paper search →-
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents
Andrew John Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz, Sophie Grande, Neil H. Goldstein, +84 more
173citations -
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial2021 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access
Muhammed Olanrewaju Afolabi, David Ishola, Daniela Manno, Babajide Keshinro, Viki Bockstal, Baimba Rogers, +80 more
96citations -
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial2021 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 2 patents
David Ishola, Daniela Manno, Muhammed Olanrewaju Afolabi, Babajide Keshinro, Viki Bockstal, Baimba Rogers, +78 more
94citations -
Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers2020 Cell Reports article Medicine Viral Infections and Outbreaks Research Open access cited by 15 patents
Lucy Rutten, Morgan S. A. Gilman, Sven Blokland, Jarek Juraszek, Jason S. McLellan, Johannes P. M. Langedijk
80citations -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa2021 PLoS Medicine article Medicine Viral Infections and Outbreaks Research Open access cited by 1 patent
Houreratou Barry, Gaudensia Nzembi Mutua, Hannah N. Kibuuka, Zacchaeus Anywaine, Sodiomon Bienvenu Sirima, Nicolas Méda, +17 more
69citations -
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
Zacchaeus Anywaine, Houreratou Barry, Omu Aggrey Anzala, Gaudensia Nzembi Mutua, Sodiomon Bienvenu Sirima, Serge Paul Eholié, +17 more
65citations -
Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study2020 The Journal of Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access
Neil H. Goldstein, Viki Bockstal, Stephan Bart, Kerstin Lühn, Cynthia Robinson, Auguste Gaddah, +2 more
41citations -
First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study
Viki Bockstal, Georgi Shukarev, Chelsea M. McLean, Neil H. Goldstein, Stephan Bart, Auguste Gaddah, +12 more
34citations -
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
Deborah Watson‐Jones, Hugo Kavunga‐Membo, Rebecca F. Grais, Steve Mundeke Ahuka, W. John Edmunds, Edward Man-Lik Choi, +11 more
30citations -
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability2023 Clinical Microbiology and Infection article Medicine Viral Infections and Outbreaks Research Open access
Angela Csaki Huttner, Sélidji Todagbé Agnandji, Olivier B. Engler, Jay W. Hooper, Steven A. Kwilas, Keersten Michelle Ricks, +43 more
27citations -
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial2022 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access
Daniela Manno, Agnes Bangura, Frank Baiden, A Kamara, Philip Ayieko, J A Kallon, +24 more
27citations -
Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign2022 The Journal of Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access
Julien M. Nyombayire, Rosine Ingabire, Ben Magod, Amelia Mazzei, Jean-Baptiste Mazarati, Jozef Noben, +10 more
27citations -
A model for establishment, maintenance and reactivation of the immune response after vaccination against Ebola virus2020 Journal of Theoretical Biology article Medicine Viral Infections and Outbreaks Research Open access
Irène Balelli, Chloé Pasin, Mélanie Prague, Fabien Crauste, Thierry Van Effelterre, Viki Bockstal, +2 more
24citations
Most active Aachen authors
-
Cynthia Robinson 1,381 citations overall32 papers
-
Kerstin Lühn 3,481 citations overall31 papers
-
Macaya Douoguih 8,403 citations overall21 papers
-
Viki Bockstal 1,654 citations overall20 papers
-
Chelsea M. McLean 1,996 citations overall15 papers
-
Babajide Keshinro 1,490 citations overall12 papers
-
Maarten Leyssen 2,275 citations overall11 papers
-
Benoît Callendret 3,320 citations overall9 papers
-
Tom H. M. Ottenhoff 38,809 citations overall8 papers
-
Georgi Shukarev 5,423 citations overall8 papers
-
Michael Katwere 495 citations overall8 papers
-
Jenny Hendriks 6,518 citations overall7 papers
-
Neil H. Goldstein 2,386 citations overall7 papers
-
Laura Solforosi 2,697 citations overall6 papers
-
Roland C. Zahn 7,046 citations overall5 papers